| Literature DB >> 23680496 |
Chris J McCormick1, Daniel R Bonanno2, Karl B Landorf2.
Abstract
BACKGROUND: The effectiveness of foot orthoses has been evaluated in many clinical trials with sham foot orthoses used as the control intervention in at least 10 clinical trials. However, the mechanical effects and credibility of sham orthoses has been rarely quantified. This study aimed to: (i) compare the effects on plantar pressures of three sham foot orthoses to a customised foot orthosis, and (ii) establish the perceived credibility and the expected benefit of each orthotic condition.Entities:
Keywords: Kinetics; Orthoses; Orthotic devices; Sham treatment
Year: 2013 PMID: 23680496 PMCID: PMC3663766 DOI: 10.1186/1757-1146-6-19
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
Summary of studies that have used a sham orthosis as a control intervention when evaluating the effectiveness of foot orthoses
| Budiman-Mak et al., 1995 [ | 102 participants with rheumatoid arthritis. | Customised orthosis constructed from Rohadur with rearfoot and forefoot posting. | Molded thin leather shell with naugahyde top cover. | At 3 years, 25% of sham group had progression of their HAV angle compared with 10% for the treatment group (statistically significant). |
| Burns et al., 2006 [ | 154 participants with painful cavoid feet. | Customised orthosis constructed with a 3 mm polypropylene shell and full length Poron® and Kashmeer top cover. | Full-length flat insole made from 3 mm latex foam with Kashmeer top cover. | At 3 months, foot pain and function scores (scale, 0–100) improved more with custom foot orthoses than with the sham, difference, 8.3 points and 9.5 points respectively (statistically significant). The customised orthosis reduced peak plantar pressures by 26% compared with 9% in the sham group (statistically significant). |
| Burns et al., 2009 [ | 61 participants with diabetes mellitus. | Customised orthosis constructed from a mesh of 8 mm Polylux, 8 mm Combilux, 2.3 mm Memorix, 3 mm Remember, and a 0.7 mm Calbino microfiber top cover (Thanner GmbH, Germany). | Removable flat, non-supportive 4 mm EVA shoe innersoles covered with a 0.7 mm Calbino top cover. | At 8 weeks, the customised and sham orthosis both provided similar improvements in foot pain and function scores. Compared to the sham group, customised group reduced peak pressure across the whole foot, 18% to 8% respectively (statistically significant). |
| Collins et al., 2009 [ | 179 participants with patellofemoral joint pain. | Prefabricated orthosis (Vasyli) made from low, medium or high density EVA. Some orthosis were heat moulded and had medial wedges and/or heel lifts added. | Full-length 3 mm flat EVA inserts, with no inbuilt arch or wedging. | At 6 weeks, the prefabricated foot orthosis produced significant improvements (19.8 mm) on the scale of global improvement compared to the sham orthosis (statistically significant). The foot orthosis provided moderate to marked improvement for 85% of participants compared to 58% for the sham orthosis. |
| Conrad et al., 1996 [ | 102 participants with rheumatoid arthritis. | Customised orthosis constructed from Rohadur with rearfoot and forefoot posting. | Molded thin leather shell with naugahyde top cover. | At 3 years, the customised and sham foot orthosis provided the same effects on disability and pain measures. |
| Finestone et al., 1999 [ | 404 participants from military infantry. | Two orthoses: (i) ‘soft’ customised polyurethane orthosis (grade 80 top layer, 60 middle layer, and 80 lower layer), and (ii) ‘semi-rigid’ customised polypropylene orthosis with rearfoot post. | Prefabricated full-length flat insole made of 3 mm polyolefin foam covered with Cambrelle®. | At 14 weeks, the ‘soft’ (10.7%) and ‘semirigid’ (15.7%) orthoses significantly reduced the incidence of the stress fractures compared to the sham orthosis (27%). |
| Landorf et al., 2006 [ | 135 participants with plantar fasciitis. | Two orthoses: (i) Customised semirigid polypropylene orthosis with heel post, and (ii) Formthotics® prefabricated three-quarter length firm density orthosis made from polyethylene foam. | 6 mm soft 120 kg/m3 EVA foam moulded to unmodified cast of participant’s foot. No top-cover. EVA shell was ground similarly to other orthoses, including being ground to approximately 1 mm thick under heel. | At 3 months, the customised and prefabricated orthoses produced significant improvements in function (scale, 0–100), 7.5 points & 8.4 points respectively, compared with the sham orthosis (statistically significant). Improvements in pain occurred in both orthotic groups compared with the sham, however these were not significant. At 12 months, no difference in pain and function was observed between orthotic groups. |
| Milgrom et al., 2005 [ | 404 participants from military infrantry. | Two orthoses: (i) ‘soft’ customised polyurethane orthosis (grade 80 top layer, 60 middle layer, and 80 lower layer), and (ii) ‘semirigid’ customised polypropylene orthosis with rearfoot post. | Prefabricated full-length flat insole made of 3 mm polyolefin foam covered with Cambrelle®. | At 14 weeks, no differences in subjective or objective measures of back pain were observed between the customised orthosis and sham groups. |
| Munteanu et al., 2009 [ | 140 participants with Achilles tendinopathy. | Customised orthosis constructed from polypropylene with a rearfoot post and covered with 2 mm Nora® Lunasoft SL. Polypropylene thickness (3.0 mm, 4.0 mm or 4.5 mm) was determined by body mass and foot posture. | 4.0 mm 90 km/m3 EVA with a 2 mm Nora® Lunasoft SL top cover. Shell was minimally ground under heel. | Study in progress. |
| Novak et al., 2009 [ | 40 participants with rheumatoid arthritis. | Customised orthosis of three layers: (i) 6 mm cork (ii) 3 mm Plastazote® and (iii) 2 mm Dynoshaum®. | ‘Unshaped’ insole of three layers: (i) 6 mm cork (ii) 3 mm Plastazote® and (iii) 2 mm Dynoshaum®. | No significant difference in pain, activity and plantar pressures was observed between the customised orthosis and sham groups. |
Participant characteristics (N = 30)
| Age in years | 25.1 (9.63) | 19 to 51 |
| Height in m | 1.70 (0.11) | 1.53 to 1.92 |
| Body mass in kgs) | 68.2 (13.8) | 44 to 96 |
| Body mass index in kg/m2 | 23.4 (4.07) | 17 to 36 |
| Foot posture index | +4 (3.84) | −4 to +10 |
| Normalised navicular height truncated | 0.24 (0.04) | 0.16 to 0.33 |
| Time on feet in h/day | 5.7 (2.0) | 3 to 12 |
Note: The foot posture index uses six criterion-based observations, which are each scored on a 5-point scale (range −2 to +2); these are then summated to produce a final score which can range from −12 (very supinated) to +12 (very pronated) [23]. The normalised navicular height truncated is the ratio of navicular height relative to the truncated foot length – with a lower ratio indicative of a flatter-arched foot [24].
Figure 1Posterior-medial view of the (i) customised foot orthosis, (ii) contoured polyethylene sham foot orthosis, (iii) contoured EVA sham foot orthosis, and (iv) flat EVA sham foot orthosis.
Mean values (SD) and percentage change for the medial and lateral heel at week 0 (N = 30)
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shoe only (control) | 215.5 (52.3) | n/a | n/a | 38.2 (6.4) | n/a | n/a | 19.7 (1.8) | n/a | n/a |
| Customised foot orthosis | 187.8 (40.3) | −13%*^ | <0.001 | 35.5 (6.4) | −7%* | 0.004 | 20.0 (1.7) | +1% | 0.495 |
| Contoured polyethylene | 204.5 (48.8) | −5%#+ | 0.180 | 35.5 (6.6) | −7%* | 0.041 | 19.7 (1.8) | 0% | 1.000 |
| Contoured EVA | 186.7 (41.9) | −13%*^ | <0.001 | 34.8 (5.7) | −9%* | <0.001 | 19.9 (1.8) | +1% | 0.879 |
| Flat EVA | 190.8 (44.8) | −11%* | 0.001 | 35.1 (6.2) | −8%* | 0.008 | 19.9 (1.7) | +1% | 0.230 |
| | |||||||||
| Shoe only (control) | 213.9 (50.5) | n/a | n/a | 37.8 (6.7) | n/a | n/a | 19.4 (1.8) | n/a | n/a |
| Customised foot orthosis | 198.8 (49.3) | −7% | 0.251 | 40.0 (7.3) | +6% | 0.134 | 19.7 (1.8) | +2% | 0.319 |
| Contoured polyethylene | 209.3 (46.9) | −2%+ | 1.000 | 39.4 (6.9) | +4% | 0.470 | 19.5 (1.8) | +1% | 1.000 |
| Contoured EVA | 191.8 (39.5) | −10%*^ | <0.001 | 38.6 (6.5) | +2% | 1.000 | 19.7 (1.8) | +2% | 0.319 |
| Flat EVA | 196.5 (52.3) | −8%* | 0.015 | 40.1 (7.2) | +6%* | 0.036 | 19.6 (1.8) | +1% | 0.568 |
* Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the shoe only condition.
# Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the customised orthosis.
Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the flat EVA sham orthosis.
+ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured EVA sham orthosis.
^ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured polyethylene orthosis.
Mean values (SD) and percentage change for the medial and lateral midfoot at week 0 (N = 30)
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shoe only (control) | 104.2 (32.1) | n/a | n/a | 8.1 (8.0)# | n/a | n/a | 14.2 (7.1) | n/a | n/a |
| Customised foot orthosis | 119.7 (33.3) | +15%*†+ | 0.017 | 15.0 (7.6)# | +86%*†+^ | <0.001 | 23.3 (3.5) | +65%*†+^ | <0.001 |
| Contoured polyethylene | 98.2 (28.8) | −6%# | 1.000 | 8.3 (8.0)# | +3%#†+ | 1.000 | 15.7 (7.6) | +11%#†+ | 0.054 |
| Contoured EVA | 101.6 (26.0) | −2%# | 1.000 | 11.4 (8.1)# | +42%*#^ | <0.001 | 19.3 (6.6) | +36%*#^ | <0.001 |
| Flat EVA | 104.3 (26.6) | 0%# | 1.000 | 12.0 (7.9)# | +49%*#^ | <0.001 | 20.0 (6.5) | +41%*#^ | <0.001 |
| | |||||||||
| Shoe only (control) | 121.7 (29.8) | n/a | n/a | 20.8 (5.4) | n/a | n/a | 23.5 (2.6) | n/a | n/a |
| Customised foot orthosis | 126.0 (26.3) | +4% | 1.000 | 25.4 (5.7) | +22%*+^ | <0.001 | 24.0 (2.1) | +2%^ | 0.166 |
| Contoured polyethylene | 121.3 (23.5) | 0% | 1.000 | 22.4 (5.6) | +8%*#† | 0.023 | 23.5 (2.4) | 0%#†+ | 1.000 |
| Contoured EVA | 118.3 (23.7) | −3% | 1.000 | 23.7 (4.5) | +14%*# | <0.001 | 24.0 (2.0) | +2%^ | 0.441 |
| Flat EVA | 115.0 (22.5) | −5%# | 0.090 | 23.9 (4.5) | +15%*^ | <0.001 | 24.0 (2.1) | +2%^ | 0.524 |
# Data transformed prior to determining significance.
* Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the shoe only condition.
# Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the customised orthosis.
† Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the flat EVA sham orthosis.
+ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured EVA sham orthosis.
^ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured polyethylene orthosis.
Mean values (SD) and percentage change for the 1st MTPJ, lateral forefoot and hallux at week 0 (N = 30)
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shoe only (control) | 179.7 (56.3) | n/a | n/a | 16.5 (6.9) | n/a | n/a | 10.0 (1.3) | n/a | n/a |
| Customised foot orthosis | 176.2 (51.6) | −2% | 1.000 | 17.1 (5.4) | +4% | 1.000 | 10.6 (1.0) | +6% | 0.425 |
| Contoured polyethylene | 176.2 (46.6) | −2% | 1.000 | 16.7 (5.4) | +1% | 1.000 | 10.7 (1.0) | +6%* | 0.020 |
| Contoured EVA | 169.1 (49.7) | −6% | 0.074 | 16.0 (5.8) | −3% | 1.000 | 10.6 (1.0) | +5% | 0.096 |
| Flat EVA | 171.3 (49.8) | −5% | 1.000 | 16.7 (5.7) | +1% | 1.000 | 10.7 (1.0) | +6% | 0.061 |
| | |||||||||
| Shoe only (control) | 204.8 (66.1) | n/a | 0.194 | 30.8 (9.2) | n/a | n/a | 18.3 (1.5) | n/a | n/a |
| Customised foot orthosis | 191.6 (54.1) | −6% | 0.194 | 30.1 (5.9) | −2%^ | 1.000 | 18.5 (1.7) | +1% | 0.252 |
| Contoured polyethylene | 205.2 (56.2) | 0%†+ | 1.000 | 32.9 (7.2) | +7%*#†+ | 0.048 | 18.5 (1.6) | +1% | 0.444 |
| Contoured EVA | 193.3 (56.9) | −6%^ | 0.665 | 30.9 (7.7) | 0%^ | 1.000 | 18.5 (1.7) | +1% | 0.252 |
| Flat EVA | 191.8 (58.2) | −6%^ | 0.177 | 30.8 (6.9) | 0%^ | 1.000 | 18.5 (1.7) | +1% | 0.533 |
| | |||||||||
| Shoe only (control) | 248.2 (58.9) | n/a | n/a | 29 .0(4.8) | n/a | n/a | 14.3 (1.2) | n/a | n/a |
| Customised foot orthosis | 258.6 (79.8) | +4% | 1.000 | 29.2 (5.3) | +1% | 1.000 | 14.1 (1.3) | −1% | 1.000 |
| Contoured polyethylene | 256.3 (91.0) | +3% | 1.000 | 28.2 (5.8) | −3% | 1.000 | 14.2 (1.2) | 0% | 1.000 |
| Contoured EVA | 259.4 (96.5) | +5% | 1.000 | 28.9 (5.5) | 0% | 1.000 | 14.2 (1.3) | 0% | 1.000 |
| Flat EVA | 260.0 (94.8) | +5% | 1.000 | 29.3 (5.4) | +1% | 1.000 | 14.3 (1.1) | 0% | 1.000 |
* Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the shoe only condition.
# Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the customised orthosis
† Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the flat EVA sham orthosis.
+ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured EVA sham orthosis.
^ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured polyethylene orthosis.
Mean values (SD) and percentage change for the medial and lateral heel at week 4 (N = 30)
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shoe only (control) | 220.8 (54.0) | n/a | n/a | 38.6 (6.9) | n/a | n/a | 19.7 (1.8) | n/a | n/a |
| Customised foot orthosis | 190.8 (37.2) | −14%*^ | <0.001 | 36.8 (6.4) | −5% | 0.072 | 20.0 (1.7) | +2% | 0.292 |
| Contoured polyethylene | 211.5 (46.8) | −4%#†+ | 0.237 | 36.9 (6.3) | −4% | 0.132 | 19.7 (1.7) | 0% | 1.000 |
| Contoured EVA | 192.8 (45.2) | −13%*^ | <0.001 | 35.6 (6.4) | −8%* | <0.001 | 19.9 (1.7) | +1% | 0.229 |
| Flat EVA | 198.8 (42.9) | −10%*^ | <0.001 | 36.7 (6.7) | −5%* | 0.008 | 19.9 (1.7) | +1% | 0.229 |
| | |||||||||
| Shoe only (control) | 221.2 (53.9) | n/a | n/a | 38.3 (7.1) | n/a | n/a | 19.4 (1.9) | n/a | n/a |
| Customised foot orthosis | 206.4 (44.6) | −7% | 0.444 | 41.1 (7.1) | +7%*+ | 0.015 | 19.6 (1.8) | +1% | 0.455 |
| Contoured polyethylene | 216.0 (45.6) | −2%†+ | 1.000 | 40.0 (6.8) | +4%+ | 0.166 | 19.6 (1.8) | +1% | 0.455 |
| Contoured EVA | 197.6 (41.4) | −11%*^ | <0.001 | 38.0 (5.9) | −1%#^ | 1.000 | 19.5 (1.8) | +1% | 1.000 |
| Flat EVA | 201.8 (42.7) | −9%*^ | <0.001 | 39.4 (7.1) | +3% | 0.745 | 19.6 (1.8) | +1% | 0.865 |
* Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the shoe only condition.
# Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the customised orthosis.
† Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the flat EVA sham orthosis.
+ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured EVA sham orthosis.
^ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured polyethylene orthosis.
Mean values (SD) and percentage change for the medial and lateral midfoot at week 4 (N = 30)
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shoe only (control) | 106.5 (30.9) | n/a | n/a | 8.2 (7.9)# | n/a | n/a | 14.4 (7.1) | n/a | n/a |
| Customised foot orthosis | 119.3 (32.1) | +12%*†+^ | 0.040 | 14.9 (7.5)# | +81%*†+^ | <0.001 | 23.3 (3.9) | +62%*†+^ | <0.001 |
| Contoured polyethylene | 102.5 (30.7) | −4%# | 1.000 | 9.0 (8.4)# | +10%#†+ | 0.354 | 16.1 (7.5) | +11%#†+ | 0.486 |
| Contoured EVA | 104.5 (29.0) | −2%# | 1.000 | 12.3 (7.8)# | +49%*#^ | <0.001 | 20.6 (6.2) | +43%*#^ | <0.001 |
| Flat EVA | 106.5 (29.6) | 0%# | 1.000 | 12.2 (7.7)# | +48%*#^ | <0.001 | 20.5 (6.1) | +42%*#^ | <0.001 |
| | |||||||||
| Shoe only (control) | 125.6 (33.9) | n/a | n/a | 21.5 (5.4) | n/a | n/a | 23.5 (2.4) | n/a | n/a |
| Customised foot orthosis | 131.4 (30.3) | +5%†+ | 1.000 | 25.4 (5.4) | +18%*†+^ | <0.001 | 24.1 (2.0) | +3%^ | 0.131 |
| Contoured polyethylene | 125.4 (29.5) | 0% | 1.000 | 23.4 (5.4) | +9%*# | 0.001 | 23.6 (2.3) | +1%# | 1.000 |
| Contoured EVA | 119.2 (26.0) | −5%# | 0.930 | 23.7 (4.7) | +10%*# | 0.002 | 24.1 (2.2) | +2% | 0.305 |
| Flat EVA | 120.6 (30.8) | −4%# | 0.909 | 24.1 (5.3) | +12%*# | <0.001 | 24.1 (2.2) | +3% | 0.216 |
# Data transformed prior to determining significance.
* Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the shoe only condition.
# Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the customised orthosis.
† Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the flat EVA sham orthosis.
+ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured EVA sham orthosis.
^ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured polyethylene orthosis.
Mean values (SD) and percentage change for the 1st MTPJ, lateral forefoot and hallux at week 4 (N = 30)
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shoe only (control) | 180.1 (51.8) | n/a | n/a | 16.3 (6.6) | n/a | n/a | 10.1 (1.1) | n/a | n/a |
| Customised foot orthosis | 180.6 (47.2) | 0% | 1.000 | 17.6 (5.1) | +8% | 0.658 | 10.7 (1.0) | +6% | 0.090 |
| Contoured polyethylene | 178.2 (43.9) | −1% | 1.000 | 16.4 (5.4) | +1% | 1.000 | 10.7 (1.1) | +6% | 0.104 |
| Contoured EVA | 176.2 (46.5) | −2% | 1.000 | 16.2 (6.1) | 0% | 1.000 | 10.6 (1.0) | +6%* | 0.016 |
| Flat EVA | 177.7 (43.6) | −1% | 1.000 | 16.5 (5.3) | +2% | 1.000 | 10.7 (1.0) | +6%* | 0.037 |
| | |||||||||
| Shoe only (control) | 212.1 (67.1) | n/a | n/a | 32.2 (10.2) | n/a | n/a | 18.4 (1.6) | n/a | n/a |
| Customised foot orthosis | 200.8 (57.1) | −5% | 1.000 | 31.1 (7.5) | −4%^ | 1.000 | 18.5 (1.7) | +1% | 0.230 |
| Contoured polyethylene | 213.3 (65.0) | +1%+ | 0.984 | 33.4 (9.0) | +3%#+ | 1.000 | 18.5 (1.7) | +1% | 0.230 |
| Contoured EVA | 200.3 (59.6) | −6% | 0.504 | 30.8 (8.3) | −4%^ | 0.582 | 18.5 (1.7) | +1% | 0.230 |
| Flat EVA | 204.8 (63.6) | −3%^ | 1.000 | 32.2 (9.2) | 0% | 1.000 | 18.5 (1.7) | +1% | 0.733 |
| | |||||||||
| Shoe only (control) | 250.2 (68.6) | n/a | n/a | 29.0 (6.1) | n/a | n/a | 14.2 (1.3) | n/a | n/a |
| Customised foot orthosis | 268.1 (102.1) | +7% | 0.779 | 29.0 (6.4) | 0% | 1.000 | 14.2 (1.2) | 0% | 1.000 |
| Contoured polyethylene | 253.6 (92.4) | +1% | 1.000 | 28.4 (6.7) | −2% | 1.000 | 14.3 (1.2) | +1% | 1.000 |
| Contoured EVA | 254.0 (80.2) | +2% | 1.000 | 29.5 (6.1) | +2% | 1.000 | 14.3 (1.3) | +1% | 1.000 |
| Flat EVA | 263.0 (96.8) | +5% | 1.000 | 29.2 (7.2) | +1% | 1.000 | 14.2 (1.3) | +1% | 1.000 |
* Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the shoe only condition.
# Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the customised orthosis.
† Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the flat EVA sham orthosis.
+ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured EVA sham orthosis.
^ Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the contoured polyethylene orthosis.
Mean values (SD) for the credibility/expectancy questionnaire (CEQ) (N = 30)
| Question | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
| 1. At this point, how logical does the treatment offered seem? | 6.53 (1.43) | 5.10 (2.01)* | 6.17 (1.62) | 5.87 (2.01) |
| 2. At this point, how successfully do you think this treatment will be in benefiting you? | 6.47 (1.41) | 4.73 (2.07)* | 5.90 (1.63) | 5.63 (1.81) |
| 3. How confident would you be in recommending this treatment to a friend who experiences similar problems? | 6.27 (1.60) | 4.73 (2.30)* | 5.90 (1.83) | 5.73 (2.17) |
| 4. By the end of the treatment period, how much benefit do you think will occur? | 60% (21%) | 42% (30%)* | 54% (24%) | 51% (27%) |
| 5. At this point, how much do you really feel that the treatment will benefit you? | 6.03 (1.56) | 4.67 (2.22) | 5.87 (1.74) | 5.27 (2.00) |
| 6. By the end of the treatment period, how much benefit do you really feel will occur? | 58% (22%) | 41% (31%)* | 54% (25%) | 49% (25%) |
* Mean difference significant at the 0.05 level (Bonferroni adjusted) compared to the customised foot orthosis.